Tag: specialty pharmaceutical company
January 25, 2019
Eton Pharmaceuticals Announces Licensing of Oral Liquid Product Candidate ET-104
Eton Pharmaceuticals (NASDAQ:ETON), a specialty pharmaceutical company focused on developing and commercializing innovative drug products, today announced that it has...
January 7, 2019
Medexus Files Business Acquisition Report
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) (the “Company”) (TSXV: MDP, OTCQB: PDDPF) today announced the filing of the Business Acquisition Report (“BAR”) on...
October 31, 2018
Acerus Announces Expansion of NATESTO® Agreement with medac and the Submission of NATESTO® Dossier in Europe
Acerus Pharmaceuticals Corporation (TSX:ASP) (“Acerus” or the “Company”) today announced the signing of an amendment to its existing licensing and... October 30, 2018
Acerus Announces Executive Leadership Changes in Corporate Finance
Acerus Pharmaceuticals Corporation (the “Company” or “Acerus”) (TSX:ASP) today announced that Robert M. Motz will join the Company as Chief...
July 15, 2018
5 Top Weekly NASDAQ Biotech Stocks: Arbutus on Top
Adamis Pharmaceutical, Juniper Pharmaceuticals, Anavex Life Sciences, Arbutus BioPharma and Soleno Therapeutics were last week's top gainers on the NASDAQ... May 9, 2018
Foamix Reports First Quarter 2018 Financial Results and Provides Corporate Update
Foamix Pharmaceuticals (NASDAQ:FOMX) a clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary topical foams to address unmet needs... May 9, 2018